Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2703-2709

  Muller M ^a,b   Haag, O ^a   Burgdorff, T ^a   Georgopoulos, A ^a   Weninger, W ^a   Jansen, B ^a   Stanek, G ^a   Pehamberger, H ^a   Agneter, E ^a   Eichler, H G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CEFODIZIME; CEFPIROME; DIRITHROMYCIN; FLEROXACIN;

ADIPOSE TISSUE; ADULT; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG MONITORING; DRUG PENETRATION; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0342818241     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2703     Document Type: Article

References (34)

1. Arai, S., S. Tabata, S. Kobayashi, M. Inazu, and S. Hayashi. 1989. Pharmacokinetic study of cefodizime in experimentally infected animals. Arzneimittelforschung 39:877-882.
2. Bauernfeind, A. 1993. In vitro activity of dirithromycin in comparison with other new and established macrolides. J. Antimicrob. Chemother. 31(Suppl. C):39-49.
3. Bergogne-Berezin, E. 1993. Tissue distribution of dirithromycin: comparison with erythromycin. J. Antimicrob. Chemother. 31(Suppl. C):77-87.
4. Blöchl-Daum, B., M. Müller, V. Meisinger, H. G. Eichler, A. Fassolt, and H. Pehamberger. 1996. Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis. Br. J. Cancer 73:920-924.
5. Bremner, D. A., A. S. Dickie, and K. P. Singh. 1988. In vito activity of fleroxacin compared with three other chinolones. J. Antimicrob. Chemother. 22(Suppl. D):19-23.
6. Cakmakci, M., L. Gossweiler, J. Schilling, R. Schlumpf, and S. Geroulanos. 1992. Penetration of fleroxacin into human lung, muscle, and fat tissue. Drugs Exp. Clin. Res. 18(7):299-302.
7. DeGuchi, Y., T. Terasaki, H. Yamada, and A. Tsuji. 1992. An application of microdialysis to drug distribution study: in vivo evidence for free ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fluids. J. Pharmacobiodyn. 15(2):79-89.
8. 18F]fleroxacin in healthy human subjects by using positron emission tomography. Antimicrob. Agents Chemother. 37:2144-2152.
9. Georgopoulos, A. 1978. A simple microagar diffusion method for the determination of antibiotic concentrations in blood and other body fluids. Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. A Reihe 242: 387-393.
10. Griggs, D. J., R. Wise, B. Kirkpatrick, and J. P. Ashby. 1988. The metabolism and pharmacokinetics of fleroxacin in healthy subjects. J. Antimicrob. Chemother. 22(Suppl. D):191-194.
11. Hyatt, J. M., P. S. McKinnon, G. S. Zimmer, and J. J. Schentag. 1995. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Clin. Pharmacokinet. 28:143-160.
12. Jones, R. N., M. A. Pfaller, S. D. Allen, E. H. Gerlach, P. C. Fuchs, and K. E. Aldridge. 1991. Antimicrobial activity of cefpirome: an update compared to five third generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. Diagn. Microbiol. Infect. Dis. 14:361-354.
13. Jynge, P., T. Skjetne, and I. Gribbestad. 1990. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin. Pbarmacol. Ther. 48:481-485.
14. Kavi, J., J. M. Andrews, J. P. Ashby, G. Hillman, and R. Wise. 1988. Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin. J. Antimicrob. Chemother. 22:911-916.
15. Korting, H. C., M. Schafer-Korting, L. Maass, N. Kiesel, and E. Mutschler. 1987. Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers. Antimicrob. Agents Chemother. 31:1822-1825.
16. Lönnroth, P., P. A. Jansson, and U. Smith. 1987. A microdialysis method allowing characterization of interstitial water space in humans. Am. J. Physiol. Endocrin. Metab. 16:E228-E231.
17. Mtairag, E. M., H. Abdelghaffar, and M. T. Labro. 1994. Investigation of dirithromycin and erythromyclamine uptake by human neutrophils in vitro. J. Antimicrob. Chemother. 33:523-526.
18. Müller, M., R. Schmid, A. Georgopoulos, A. Buxbaum, C. Wasicek, and H. G. Eichler. 1995. Application of microdialysis to clinical pharmacokinetics in humans. Clin. Pharmacol. Ther. 57:371-380.
19. Müller, M., R. Schmid, M. Nieszpaur-Los, P. Lönnroth, A. Molnar, P. Fasching, and H. G. Eichler. 1995. Key metabolite kinetics in human skeletal muscle during ischemia and reperfusion: measurement by microdialysis. Eur. J. Clin. Invest. 25:601-607.
20. Müller, M., R. Schmid, H. Shayganfar, O. Wagner, B. v. Osten, and H. G. Eichler. 1995. In vivo characterization of transdermal drug transport by microdialysis. J. Controlled Release 37:49-57.
21. Müller, M., B. von Osten, R. Schmid, E. Piegler, I. Gerngroß, H. Buchegger, and H. G. Eichler. 1995. Theophylline kinetics in peripheral tissues in vivo in humans. NS Arch. Pharmacol. 352:438-441.
22. Nowak, A., and A. Klimowicz. 1990. Two stage penetration of a single oral dose of sulphadimethoxine into skin blister fluid. Eur. J. Clin. Pharmacol. 39:487-490.
23. Portmann, R., and E. Weidekamm. 1992. Penetration of fleroxacin into human and animal tissues. Chemotherapy (Basel) 38:145-149.
24. Roos, K., and J. E. Brorson. 1990. Concentration of phenoxymethylpenicillin in tonsillar tissue. Eur. J. Clin. Pharmacol. 39:417-418.
25. Ryan, D. M. 1993. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J. Antimicrob. Chemother. 31(Suppl. D):1-16.
26. Ryan, D. M., and O. Cars. 1983. A problem in the interpretation of beta-lactam antibiotic levels in tissues. J. Antimicrob. Chemother. 12:281-284.
27. Ryan, D. M., O. Cars, and B. Hoffstedt. 1986. The use of antibiotic scrum concentrations to predict concentrations in tissues. Scand. J. Infect. Dis. 18:381-388.
28. Scheyer, R. D., M. J. During, D. D. Spencer, J. A. Cramer, and R. H. Mattson. 1994. Measurement of carbamazepine and carbamazepine epoxide in the human brain using in vivo microdialysis. Neurology 44:1469-1472.
29. Sides, G. D., B. J. Cerimele, H. R. Black, U. Busch, and K. A. DeSante. 1993. Pharmacokinetics of dirithromycin. J. Antimicrob. Chemother. 31(Suppl. C):65-75.
30. Soussy, C. J., M. Chanal, and M. D. Kitzis. 1990. The in vitro activity of cefodizime: a review. J. Antimicrob. Chemother. 26(Suppl. C):13-21.
31. Strömberg, A., U. Friberg, and O. Cars. 1987. Concentrations of phenoxymethylpenicillin and cefradoxil in tonsillar tissue and tonsillar surface fluid. Eur. J. Microbiol. 6:525-529.
32. Tang-Liu, D. S., D. L. Schwob, J. I. Usansky, and Y. J. Gordon. 1994. Comparative tear concentrations over time of ofloxacin and tobramycin in human eyes. Clin. Pharmacol. Ther. 55:284-292.
33. Ungerstedt, U. 1991. Microdialysis - principles and applications for studies in animals and man. J. Intern. Med. 230:365-373.
34. Yamamoto, T., H. Kusajima, M. Hosaka, and H. Shinoda. 1995. Uptake and intracellular activity of fleroxacin in phagocytic cells. Chemotherapy (Tokyo) 41:353-359.